CClinicalTrials.gg
RecruitingNCT07494318Updated Jun 10, 2026

Advanced GastroInstestinal(GI) Surgery Training in Residency and Fellowship.

An observational study in Gastro-Intestinal Disorder, sponsored by Methodist Health System. Recruiting at 1 site in United States. Per ClinicalTrials.gov, last updated 2026-06-10.

Sponsored by Methodist Health System · Observational

From the registry’s dates

  • Started Aug 2018; still recruiting 8 years 2 months later.
Study type
Observational
Model
Other
Time perspective
Retrospective
Enrollment
260
Sex
All
01

Study summary

The aim of this anonymous survey is to identify who teaches GI procedures to general surgical residents during residency training and understand the need as well as desire for an Advanced Surgical GI fellowship amongst senior surgical residents. We also hope to identify the self-reported level of comfort of senior general surgery residents in completing both common and complex GI procedures.

Read the detailed description

Graduating general surgery residents are faced with the difficult decision of whether to pursue further specialized surgical fellowship training or to begin independent general surgical practice. Advanced GI Fellowship is a relatively new area of fellowship surgical training, with only 8 fellowships currently recognized by the Fellowship Council of the United States. The previous survey assessed the need for such a fellowship among health systems, departments, and practice groups interested in hiring a GI surgeon. More data is coming out showing that graduating surgical residents are unprepared to independently perform core general surgery procedures. Therefore, it is vitally important to be able to understand not only who are teaching general surgery residents GI surgical procedures, but also the residents' self-reported competence with GI procedures, and personal experience and degree of comfort managing both common and complex GI surgical pathologies.

02

Conditions studied

  • Gastro-Intestinal Disorder
03

In context

Digestive System Diseases

613 studies on the registry are indexed under Digestive System Diseases; 117 are open to participants now.

This study's planned enrollment of 260 is close to the median of 272 across 193 observational studies indexed under Digestive System Diseases.

Browse Digestive System Diseases studies →

Lead sponsor

Methodist Health System is the lead sponsor of 169 studies on the registry; 52 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

There are 260 ACGME-accredited general surgery programs in the United States. Each program can have 1-13 residents per year.

Inclusion criteria

All fourth and fifth year general surgery residents in accredited Accreditation Council for Graduate Medical Education(ACGME) general surgery residency programs in the United States.

Exclusion criteria

Exclusion Criteria:

All junior general surgical residents (third year residents through interns) will be excluded from the study.

05

Study design

Observational model
Other
Time perspective
Retrospective
Enrollment
260 participants (estimated)
Patient registry
No

Interventions

  • OtherAdvanced GI Surgery Training

    Determine who is training senior surgical residents in advanced GI surgical procedures and the trainees' comfort with performing complex GI procedures following residency training.

06

What researchers measure

Primary outcomes

  1. Training senior general surgical residents

    Gain further understanding in who is training senior general surgical residents in advanced GI surgery during residency training.

    Time frame: 1 year

07

Study locations

1 of 1 sites recruiting
  • Methodist Dallas Medical Center- Clinical Research Institute
    Dallas, Texas 75203, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — All information will be blinded in compliance with Good Clinical Practice(GCP). The investigator will make all possible efforts to ensure compliance with all policies regarding sharing of Protected Health Information(PHI) or research information. Only de-identified PHI will be shared in relevant research mediums. These mediums may range from national, regional, local and/or international sites. In addition, study data and findings may be submitted for presentation at local and national conferences.

Supporting information: Study protocol

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07494318
Lead sponsor
Methodist Health System
Responsible party
Sponsor
First posted
Mar 27, 2026
Start date
Aug 2, 2018
Primary completion
Jan 2027 (estimated)
Completion
Jan 2028 (estimated)
Last update
Jun 10, 2026

Study contacts

Crystee Cooper, DHEd
Contact
ClinicalResearch@mhd.com
214-947-1280
Kavya Mankulangara
Contact
ClinicalResearch@mhd.com
214-947-4604
Rohan Jeyarajah, MD
principal investigator · Methodist Health System

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion